BORDEAUX, France--(BUSINESS WIRE)--FineHeart, a clinical-stage MedTech company developing innovative medical devices for heart failure, has achieved a major milestone in its "First in Human" study, ...

Heart failure symptoms have been reversed in patients with a new pacemaker that changes how the heart is fuelled.

Scientists have uncovered why people with chronic kidney disease so often die from heart problems: damaged kidneys release ...

Cytokinetics is committed to supporting patients with MYQORZO & You™, a personalized program for patients prescribed MYQORZO ...

Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...

For millions of people with heart failure, the latest treatment options — including advanced surgical procedures and innovative devices to assist a failing heart — can be game-changing, especially ...

Nonpharmacologic heart failure management and interventions can reduce cardiovascular risk factors and carotid intima-media ...

Panelists discuss how payers typically require step therapy with SGLT2 inhibitors before approving nonsteroidal MRAs due to cost considerations, while acknowledging the need for head-to-head trials to ...

A weight loss medication is showing remarkable promise in treating one of America’s most serious health conditions. New research reveals that Zepbound, already celebrated for its effectiveness in ...

In heart failure, the necessary oxygen levels and nutrients do not meet the body’s demands, setting off a domino effect of congestion in the lungs, kidneys and other areas. About 6.7 million adults in ...